Logo image of KOPN

KOPIN CORP (KOPN) Stock Fundamental Analysis

NASDAQ:KOPN - Nasdaq - US5006001011 - Common Stock - Currency: USD

1.63  0 (0%)

After market: 1.62 -0.01 (-0.61%)

Fundamental Rating

3

Overall KOPN gets a fundamental rating of 3 out of 10. We evaluated KOPN against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. The financial health of KOPN is average, but there are quite some concerns on its profitability. While showing a medium growth rate, KOPN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

KOPN had negative earnings in the past year.
In the past year KOPN has reported a negative cash flow from operations.
In the past 5 years KOPN always reported negative net income.
In the past 5 years KOPN always reported negative operating cash flow.
KOPN Yearly Net Income VS EBIT VS OCF VS FCFKOPN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -22.21%, KOPN is doing worse than 81.82% of the companies in the same industry.
The Return On Equity of KOPN (-69.84%) is worse than 87.27% of its industry peers.
Industry RankSector Rank
ROA -22.21%
ROE -69.84%
ROIC N/A
ROA(3y)-48.71%
ROA(5y)-35.33%
ROE(3y)-111.71%
ROE(5y)-76.86%
ROIC(3y)N/A
ROIC(5y)N/A
KOPN Yearly ROA, ROE, ROICKOPN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

KOPN has a Gross Margin of 30.66%. This is in the lower half of the industry: KOPN underperforms 71.82% of its industry peers.
In the last couple of years the Gross Margin of KOPN has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for KOPN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.52%
GM growth 5Y-0.7%
KOPN Yearly Profit, Operating, Gross MarginsKOPN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

5

2. Health

2.1 Basic Checks

KOPN does not have a ROIC to compare to the WACC, probably because it is not profitable.
KOPN has more shares outstanding than it did 1 year ago.
KOPN has more shares outstanding than it did 5 years ago.
KOPN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
KOPN Yearly Shares OutstandingKOPN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
KOPN Yearly Total Debt VS Total AssetsKOPN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

KOPN has an Altman-Z score of -4.78. This is a bad value and indicates that KOPN is not financially healthy and even has some risk of bankruptcy.
KOPN's Altman-Z score of -4.78 is on the low side compared to the rest of the industry. KOPN is outperformed by 79.09% of its industry peers.
There is no outstanding debt for KOPN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.78
ROIC/WACCN/A
WACC10.08%
KOPN Yearly LT Debt VS Equity VS FCFKOPN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

KOPN has a Current Ratio of 1.40. This is a normal value and indicates that KOPN is financially healthy and should not expect problems in meeting its short term obligations.
KOPN has a Current ratio of 1.40. This is amonst the worse of the industry: KOPN underperforms 84.55% of its industry peers.
A Quick Ratio of 1.25 indicates that KOPN should not have too much problems paying its short term obligations.
KOPN's Quick ratio of 1.25 is on the low side compared to the rest of the industry. KOPN is outperformed by 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 1.25
KOPN Yearly Current Assets VS Current LiabilitesKOPN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

KOPN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 71.05%, which is quite impressive.
KOPN shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.16%.
Measured over the past years, KOPN shows a quite strong growth in Revenue. The Revenue has been growing by 11.28% on average per year.
EPS 1Y (TTM)71.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.59%
Revenue 1Y (TTM)28.16%
Revenue growth 3Y3.27%
Revenue growth 5Y11.28%
Sales Q2Q%5.03%

3.2 Future

The Earnings Per Share is expected to grow by 17.66% on average over the next years. This is quite good.
KOPN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.04% yearly.
EPS Next Y89.61%
EPS Next 2Y40.75%
EPS Next 3Y28.9%
EPS Next 5Y17.66%
Revenue Next Year11.05%
Revenue Next 2Y15.92%
Revenue Next 3Y17.09%
Revenue Next 5Y14.04%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
KOPN Yearly Revenue VS EstimatesKOPN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
KOPN Yearly EPS VS EstimatesKOPN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KOPN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KOPN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KOPN Price Earnings VS Forward Price EarningsKOPN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KOPN Per share dataKOPN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 0.3

4.3 Compensation for Growth

A more expensive valuation may be justified as KOPN's earnings are expected to grow with 28.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.75%
EPS Next 3Y28.9%

More info and screens

0

5. Dividend

5.1 Amount

KOPN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KOPIN CORP

NASDAQ:KOPN (6/20/2025, 8:00:02 PM)

After market: 1.62 -0.01 (-0.61%)

1.63

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-06 2025-08-06
Inst Owners32.4%
Inst Owner Change12.48%
Ins Owners2.58%
Ins Owner Change3.97%
Market Cap265.36M
Analysts84
Price Target2.47 (51.53%)
Short Float %2.54%
Short Ratio1.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.63%
Min EPS beat(2)-30.72%
Max EPS beat(2)43.98%
EPS beat(4)2
Avg EPS beat(4)4.3%
Min EPS beat(4)-30.72%
Max EPS beat(4)43.98%
EPS beat(8)3
Avg EPS beat(8)-61.44%
EPS beat(12)5
Avg EPS beat(12)-47.12%
EPS beat(16)8
Avg EPS beat(16)-35.38%
Revenue beat(2)1
Avg Revenue beat(2)3.13%
Min Revenue beat(2)-9.44%
Max Revenue beat(2)15.7%
Revenue beat(4)3
Avg Revenue beat(4)7.91%
Min Revenue beat(4)-9.44%
Max Revenue beat(4)21.73%
Revenue beat(8)5
Avg Revenue beat(8)4.65%
Revenue beat(12)7
Avg Revenue beat(12)3.35%
Revenue beat(16)9
Avg Revenue beat(16)1.64%
PT rev (1m)-0.85%
PT rev (3m)-3.33%
EPS NQ rev (1m)-33.3%
EPS NQ rev (3m)-33.3%
EPS NY rev (1m)-57.18%
EPS NY rev (3m)30.15%
Revenue NQ rev (1m)-8.94%
Revenue NQ rev (3m)-21.94%
Revenue NY rev (1m)-0.47%
Revenue NY rev (3m)-2.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.22
P/FCF N/A
P/OCF N/A
P/B 12.83
P/tB 12.83
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.31
BVpS0.13
TBVpS0.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.21%
ROE -69.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.66%
FCFM N/A
ROA(3y)-48.71%
ROA(5y)-35.33%
ROE(3y)-111.71%
ROE(5y)-76.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.52%
GM growth 5Y-0.7%
F-Score4
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 162.01%
Cap/Sales 2.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 1.25
Altman-Z -4.78
F-Score4
WACC10.08%
ROIC/WACCN/A
Cap/Depr(3y)133.16%
Cap/Depr(5y)127.26%
Cap/Sales(3y)1.91%
Cap/Sales(5y)1.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.59%
EPS Next Y89.61%
EPS Next 2Y40.75%
EPS Next 3Y28.9%
EPS Next 5Y17.66%
Revenue 1Y (TTM)28.16%
Revenue growth 3Y3.27%
Revenue growth 5Y11.28%
Sales Q2Q%5.03%
Revenue Next Year11.05%
Revenue Next 2Y15.92%
Revenue Next 3Y17.09%
Revenue Next 5Y14.04%
EBIT growth 1Y35.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year95.43%
EBIT Next 3Y31.42%
EBIT Next 5YN/A
FCF growth 1Y22.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.77%
OCF growth 3YN/A
OCF growth 5YN/A